Evidence map›Paper›PMID 31073700›Full record

ArticleBiological trace element research2020

Comparison of the Wild-Type Obligate Methylotrophic Bacterium Methylophilus quaylei and its Isogenic Streptomycin-Resistant Mutant via Metal Nanoparticle Generation.

Vladimir V Sorokin, Anna B Pshenichnikova, Sergei V Kalenov, Nikolay A Suyasov, Dmitry A Skladnev

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Biological trace element research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vladimir V SorokinWinogradsky Institute of Microbiology, Research Center of Biotechnology of the Russian Academy of Sciences, 33, Bld. 2 Leninsky Ave., Moscow, Russia.
Anna B PshenichnikovaDepartment of Biotechnology and Industrial Pharmacy, MIREA - Russian Technological University, 86 Vernadsky Avenue, Moscow, Russia.
Sergei V KalenovDepartment of Biotechnology, Faculty of Biotechnology and Industrial Ecology, D.I. Mendeleyev University of Chemical Technology of Russia, 9 Miusskaya Square, Moscow, Russia. wsezart@yandex.ru.ORCID http://orcid.org/0000-0001-9181-6950
Nikolay A SuyasovDepartment of Biotechnology, Faculty of Biotechnology and Industrial Ecology, D.I. Mendeleyev University of Chemical Technology of Russia, 9 Miusskaya Square, Moscow, Russia.
Dmitry A SkladnevWinogradsky Institute of Microbiology, Research Center of Biotechnology of the Russian Academy of Sciences, 33, Bld. 2 Leninsky Ave., Moscow, Russia.
D. Mendeleyev University of Chemical Technology of Russia · RURussian Academy of Sciences · RUMIREA - Russian Technological University · RU

Funding

Mendeleyev University of Chemical Technology of Russia Project Number 033-2018
6 · The paper itself

Abstract

Metal nanoparticles synthesized by green methods with the use of microorganisms are currently one of the most closely studied types of nanomaterials. It has accurately been shown that the characteristics of metal nanoparticles generated in the presence of different bacteria vary. For the two isogenic strains of obligate methylotrophic bacteria of the wild type (M. quaylei MT

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGenetic PleiotropyMetal NanoparticlesMethylophilusMicrobial Sensitivity TestsMutationPalladiumSilverStreptomycinAnti-Bacterial AgentsPalladiumSilverStreptomycinBiogenic nanoparticlesMethylotrophic bacteriumPalladium nanoparticlesSilver nanoparticles

Identifiers

PMID31073700
PMCPMC6944653
OpenAlexW2943908839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.